Australia markets closed

Offerpad Solutions Inc. (OPAD)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
8.10-0.44 (-5.15%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 221.01M
Enterprise value 404.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.16
Price/book (mrq)2.17
Enterprise value/revenue 0.31
Enterprise value/EBITDA -4.15

Trading information

Stock price history

Beta (5Y monthly) 2.08
52-week change 32.47%
S&P500 52-week change 327.86%
52-week high 315.19
52-week low 36.00
50-day moving average 38.68
200-day moving average 39.69

Share statistics

Avg vol (3-month) 326.06k
Avg vol (10-day) 324.73k
Shares outstanding 527.29M
Implied shares outstanding 628.77M
Float 814.81M
% held by insiders 111.18%
% held by institutions 147.31%
Shares short (15 Mar 2024) 4924.79k
Short ratio (15 Mar 2024) 427.6
Short % of float (15 Mar 2024) 48.53%
Short % of shares outstanding (15 Mar 2024) 43.39%
Shares short (prior month 15 Feb 2024) 4921.59k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:15
Last split date 313 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -8.92%
Operating margin (ttm)-4.68%

Management effectiveness

Return on assets (ttm)-10.83%
Return on equity (ttm)-104.82%

Income statement

Revenue (ttm)1.31B
Revenue per share (ttm)49.82
Quarterly revenue growth (yoy)-64.50%
Gross profit (ttm)N/A
EBITDA -103.69M
Net income avi to common (ttm)-117.22M
Diluted EPS (ttm)-4.21
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)75.97M
Total cash per share (mrq)2.78
Total debt (mrq)260.91M
Total debt/equity (mrq)256.36%
Current ratio (mrq)1.35
Book value per share (mrq)3.74

Cash flow statement

Operating cash flow (ttm)261.63M
Levered free cash flow (ttm)343.01M